Correlation Between Naked Wines and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Naked Wines and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Naked Wines and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Naked Wines plc and Spyre Therapeutics, you can compare the effects of market volatilities on Naked Wines and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Naked Wines with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Naked Wines and Spyre Therapeutics.
Diversification Opportunities for Naked Wines and Spyre Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Naked and Spyre is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Naked Wines plc and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Naked Wines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Naked Wines plc are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Naked Wines i.e., Naked Wines and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Naked Wines and Spyre Therapeutics
Assuming the 90 days horizon Naked Wines plc is expected to generate 1.52 times more return on investment than Spyre Therapeutics. However, Naked Wines is 1.52 times more volatile than Spyre Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 255.00 in Naked Wines plc on December 28, 2024 and sell it today you would lose (25.00) from holding Naked Wines plc or give up 9.8% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 96.77% |
Values | Daily Returns |
Naked Wines plc vs. Spyre Therapeutics
Performance |
Timeline |
Naked Wines plc |
Spyre Therapeutics |
Naked Wines and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Naked Wines and Spyre Therapeutics
The main advantage of trading using opposite Naked Wines and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Naked Wines position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Naked Wines vs. Pernod Ricard SA | Naked Wines vs. Naked Wines plc | Naked Wines vs. Crimson Wine | Naked Wines vs. Brown Forman |
Spyre Therapeutics vs. Plexus Corp | Spyre Therapeutics vs. Molecular Partners AG | Spyre Therapeutics vs. Allient | Spyre Therapeutics vs. Jabil Circuit |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |